Pacanalotamab
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3E. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines[1].
Product Specifications
CAS Number
2251756-52-0
Product Name Alternative
AMG 420; BI-836909
UNSPSC
12352203
Target
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pacanalotamab.html
Purity
97.04
Solubility
10 mM in DMSO
Smiles
[Pacanalotamab]
Molecular Weight
(53.69 kDa)
References & Citations
[1]Hipp S, et al. A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo. Leukemia. 2017 Aug;31 (8) :1743-1751.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![1-[ (4-isopropylphenyl) sulfonyl]piperazine hydrochloride](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
sc-338865A 5 g
1-[ (4-isopropylphenyl) sulfonyl]piperazine hydrochloride
Sign In for Pricing
View Details